SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas
Clinical trial NCT03894618 · COMPLETED
Trial details
- NCT number
- NCT03894618
- Sponsor
- Shattuck Labs, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2023-05-04
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.